<Record>
<Term>A-65</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Miscellaneous Angiogenesis Inhibitor</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Angiogenesis Inhibitor/Miscellaneous Angiogenesis Inhibitor/A-65</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Angiogenesis Inhibitor</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>A-65</BroaderTerm>
<BroaderTerm>Miscellaneous Angiogenesis Inhibitor</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>A-65</Synonym>
<Description>An amide analogue of Trichostatin A studied for potential antineoplastic activity.  A-65 inhibits zinc-dependent histone deacetylase, inducing terminal cell differentiation and anti-angiogenic activity. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
